Jan 11, 2024
Goleta, CA, April 10, 2023 – Vascular BioSciences announces publication of "A Bioinformatic Algorithm based on Pulmonary Endoarterial Biopsy for Targeted Pulmonary Arterial Hypertension Therapy" in the latest issue of The Open Respiratory Medicine...
Jan 11, 2024
Vascular BioSciences announces publication of "CAR Selectively Enhances the Pulmonary Vasodilatory Effect of Fasudil in a Microsphere Model of Pulmonary Hypertension" in the latest issue of The Open Respiratory Medicine (Volume 17, April 27, 2023) by...
Jun 04, 2020
CEO of Vascular BioSciences, David Mann, makes connection between current research and COVID-19 applications
Sep 06, 2019
Vascular Biosciences (VBS) received a Humanitarian Use Device (HUD) designation from the U.S.
Oct 19, 2018
Grant awarded in partnership with Brigham and Women's Hospital, Harvard Medical School to Develop CAR Peptide as a Targeted Therapy for Pulmonary Hypertension
Oct 18, 2018
Grant awarded in partnership with Brigham and Women's Hospital, Harvard Medical School
Sep 08, 2017
Project to be Conducted in Collaboration with Brigham and Women's Hospital, Harvard Medical School.
May 23, 2016
Vascular BioSciences to present the full scope of its research efforts at this year's ATS International Conference
May 26, 2015
VBS Voted By Industry Peers Best Biotech Drug Pipeline of 2015